Current report filing

Cover

v3.24.1.1.u2
Cover
Mar. 14, 2024
Document Type 8-K/A
Amendment Flag true
Amendment Description BiomX Inc. (the “Company”) is filing this Amendment No. 1 to the Company’s Current Report on Form 8-K, dated March 14, 2024 and filed with the Securities and Exchange Commission on March 18, 2024, solely for the purpose of providing the financial statements and information required by Item 9.01(a) and the pro forma financial information required by Item 9.01(b) in connection with the previously reported acquisition (the “Acquisition”) of Adaptive Phage Therapeutics, Inc., a Delaware corporation (“APT”), pursuant to that certain Agreement and Plan of Merger, by and among the Company, BTX Merger Sub I, Inc., a Delaware corporation and a wholly owned subsidiary of the Company, BTX Merger Sub II, LLC, a Delaware limited liability company and wholly owned subsidiary of the Company, and APT.             Beginning with the Company’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2024, the Company has reported results of APT and the Company on a consolidated basis.
Document Period End Date Mar. 14, 2024
Entity File Number 001-38762
Entity Registrant Name BiomX Inc.
Entity Central Index Key 0001739174
Entity Tax Identification Number 82-3364020
Entity Incorporation, State or Country Code DE
Entity Address, Address Line One 22 Einstein St.
Entity Address, Address Line Two Floor 4
Entity Address, City or Town Ness Ziona
Entity Address, Country IL
Entity Address, Postal Zip Code 7414003
City Area Code 972
Local Phone Number 723942377
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Entity Emerging Growth Company false
Units, each consisting of one share of Common Stock, $0.0001 par value, and one Warrant entitling the holder to receive one half share of Common Stock  
Title of 12(b) Security Units, each consisting of one share of Common Stock, $0.0001 par value
Trading Symbol PHGE.U
Security Exchange Name NYSE
Shares of Common Stock, $0.0001 par value  
Title of 12(b) Security Shares of Common Stock, $0.0001 par value
Trading Symbol PHGE
Security Exchange Name NYSE